220 related articles for article (PubMed ID: 20014099)
41. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
42. High throughput screening based selection of phases for aqueous two-phase system-centrifugal partitioning chromatography of monoclonal antibodies.
Oelmeier SA; Ladd Effio C; Hubbuch J
J Chromatogr A; 2012 Aug; 1252():104-14. PubMed ID: 22789754
[TBL] [Abstract][Full Text] [Related]
43. Capture of human monoclonal antibodies from cell culture supernatant by ion exchange media exhibiting high charge density.
Necina R; Amatschek K; Jungbauer A
Biotechnol Bioeng; 1998 Dec; 60(6):689-98. PubMed ID: 10099479
[TBL] [Abstract][Full Text] [Related]
44. Development, validation, and implementation of capillary gel electrophoresis as a replacement for SDS-PAGE for purity analysis of IgG2 mAbs.
Lacher NA; Roberts RK; He Y; Cargill H; Kearns KM; Holovics H; Ruesch MN
J Sep Sci; 2010 Feb; 33(2):218-27. PubMed ID: 20087870
[TBL] [Abstract][Full Text] [Related]
45. A simple high-throughput purification method for hit identification in protein screening.
Cummins E; Luxenberg DP; McAleese F; Widom A; Fennell BJ; Darmanin-Sheehan A; Whitters MJ; Bloom L; Gill D; Cunningham O
J Immunol Methods; 2008 Nov; 339(1):38-46. PubMed ID: 18760282
[TBL] [Abstract][Full Text] [Related]
46. High-throughput screening of chromatographic separations: III. Monoclonal antibodies on ceramic hydroxyapatite.
Wensel DL; Kelley BD; Coffman JL
Biotechnol Bioeng; 2008 Aug; 100(5):839-54. PubMed ID: 18551522
[TBL] [Abstract][Full Text] [Related]
47. Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass - prediction of viscosity through protein-protein interaction measurements.
Neergaard MS; Kalonia DS; Parshad H; Nielsen AD; Møller EH; van de Weert M
Eur J Pharm Sci; 2013 Jun; 49(3):400-10. PubMed ID: 23624326
[TBL] [Abstract][Full Text] [Related]
48. High-throughput mAb expression and purification platform based on transient CHO.
Barnard GC; Hougland MD; Rajendra Y
Biotechnol Prog; 2015; 31(1):239-47. PubMed ID: 25403790
[TBL] [Abstract][Full Text] [Related]
49. Optimal conditions for the papain digestion of polyclonal ovine IgG for the production of bio-therapeutic Fab fragments.
Cresswell C; Newcombe AR; Davies S; Macpherson I; Nelson P; O'Donovan K; Francis R
Biotechnol Appl Biochem; 2005 Oct; 42(Pt 2):163-8. PubMed ID: 15799716
[TBL] [Abstract][Full Text] [Related]
50. Optimization of random PEGylation reactions by means of high throughput screening.
Maiser B; Dismer F; Hubbuch J
Biotechnol Bioeng; 2014 Jan; 111(1):104-14. PubMed ID: 23939788
[TBL] [Abstract][Full Text] [Related]
51. Engineering of a two-step purification strategy for a panel of monoclonal immunoglobulin M directed against undifferentiated human embryonic stem cells.
Tscheliessnig A; Ong D; Lee J; Pan S; Satianegara G; Schriebl K; Choo A; Jungbauer A
J Chromatogr A; 2009 Nov; 1216(45):7851-64. PubMed ID: 19815220
[TBL] [Abstract][Full Text] [Related]
52. Limitations of polyethylene glycol-induced precipitation as predictive tool for protein solubility during formulation development.
Hofmann M; Winzer M; Weber C; Gieseler H
J Pharm Pharmacol; 2018 May; 70(5):648-654. PubMed ID: 28106257
[TBL] [Abstract][Full Text] [Related]
53. A survey of protein-protein complex crystallizations.
Radaev S; Li S; Sun PD
Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):605-12. PubMed ID: 16699187
[TBL] [Abstract][Full Text] [Related]
54. High productivity purification of immunoglobulin G monoclonal antibodies on starch-coated magnetic nanoparticles by steric exclusion of polyethylene glycol.
Gagnon P; Toh P; Lee J
J Chromatogr A; 2014 Jan; 1324():171-80. PubMed ID: 24315125
[TBL] [Abstract][Full Text] [Related]
55. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.
Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
J Biomol Screen; 2014 Oct; 19(9):1290-301. PubMed ID: 25023322
[TBL] [Abstract][Full Text] [Related]
56. Development of a high throughput protein a well-plate purification method for monoclonal antibodies.
Hopp J; Pritchett R; Darlucio M; Ma J; Chou JH
Biotechnol Prog; 2009; 25(5):1427-32. PubMed ID: 19637390
[TBL] [Abstract][Full Text] [Related]
57. Decision-support software for the industrial-scale chromatographic purification of antibodies.
Chhatre S; Thillaivinayagalingam P; Francis R; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
Biotechnol Prog; 2007; 23(4):888-94. PubMed ID: 17630695
[TBL] [Abstract][Full Text] [Related]
58. Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay.
Meza NP; Hardy CA; Morin KH; Huang C; Raghava S; Song J; Zhang J; Wang Y
Mol Pharm; 2023 Nov; 20(11):5842-5855. PubMed ID: 37867303
[TBL] [Abstract][Full Text] [Related]
59. Interactions and phase behavior of a monoclonal antibody.
Lewus RA; Darcy PA; Lenhoff AM; Sandler SI
Biotechnol Prog; 2011; 27(1):280-9. PubMed ID: 21312375
[TBL] [Abstract][Full Text] [Related]
60. Selection of pH-related parameters in ion-exchange chromatography using pH-gradient operations.
Ahamed T; Chilamkurthi S; Nfor BK; Verhaert PD; van Dedem GW; van der Wielen LA; Eppink MH; van de Sandt EJ; Ottens M
J Chromatogr A; 2008 Jun; 1194(1):22-9. PubMed ID: 18154981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
